药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Halothane
Rotigotine
Levocetirizine may increase the sedative activities of Rotigotine.
Halothane
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.
Halothane
Paraldehyde
Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Halothane
Orphenadrine
Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Halothane
Methotrimeprazine
Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Bretylium
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Amrubicin.
Bretylium
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Amrubicin.
Gemifloxacin
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Droxidopa.
Gemifloxacin
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Droxidopa.
Gemifloxacin
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Droxidopa.
Gemifloxacin
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Droxidopa.
Gemifloxacin
Palmidrol
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Palmidrol.
Gemifloxacin
Nabiximols
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Nabiximols.
Gemifloxacin
Medical Cannabis
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Medical Cannabis.
Gemifloxacin
WIN 55212-2
The risk or severity of Tachycardia can be increased when Droxidopa is combined with WIN 55212-2.
Gemifloxacin
Timepidium
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Timepidium.
Gemifloxacin
Pipenzolate
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Pipenzolate.
Gemifloxacin
Emetonium iodide
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Emetonium iodide.
Gemifloxacin
Fenpiverinium
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Fenpiverinium.
Gemifloxacin
Camylofin
The risk or severity of Tachycardia can be increased when Droxidopa is combined with Camylofin.